Concepedia

Author

Norman Stockbridge

United States Food and Drug Administration

Also Known As

Anker, Stefan D., John R. Teerlink, Motiur Rahman, N L Stockbridge, N STOCKBRIDGE, N Stockbridge, N. Stockbridge, NORMAN STOCKBRIDGE, Norman L Stockbridge, Norman L. Stockbridge

247

Publications

11.7K

Citations

54

H-Index

148

Concepts

All Affiliations

United States Food and Drug AdministrationCenter for Drug Evaluation and ResearchClinical Research InstituteUniversity of AlbertaDuke Medical Center
NS

About

Norman Stockbridge is an author at United States Food and Drug Administration specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

29

43

3.1K

2

Public Health

12

13

1.3K

3

Health Sciences

5

5

128

4

Engineering

3

3

141

5

Natural Sciences

1

1

98

Norman Stockbridge

×

83

Publications

5.9K

Citations

37

H-Index

YearCitations

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

Philip Urban, Roxana Mehran, Róisín Colleran,

European Heart Journal

2019

540

Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium

Philip T. Sager, Gary A. Gintant, J. Rick Turner,

American Heart Journal

2013

536

The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress

Thomas Colatsky, Bernard Fermini, Gary A. Gintant,

Journal of Pharmacological and Toxicological Methods

2016

443

International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment

Ksenia Blinova, Qianyu Dang, Daniel Millard,

Cell Reports

2018

358

Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias

Ksenia Blinova, Jayna Stohlman, José Vicente,

Toxicological Sciences

2016

271

Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil

Lars Johannesen, José Vicente, Jay W. Mason,

Clinical Pharmacology & Therapeutics

2014

257

Clinical Outcome Endpoints in Heart Failure Trials: A European Society of Cardiology Heart Failure Association Consensus Document

Faı̈ez Zannad, Ángeles García, Stefan D. Anker,

European Journal of Heart Failure

2013

229

Results From the IQ‐CSRC Prospective Study Support Replacement of the Thorough QT Study by QT Assessment in the Early Clinical Phase

Börje Darpö, Charles Benson, Corina Dota,

Clinical Pharmacology & Therapeutics

2015

176

Late sodium current block for drug‐induced long QT syndrome: Results from a prospective clinical trial

Lars Johannesen, José Vicente, Mason Jw,

Clinical Pharmacology & Therapeutics

2015

142

Presynaptic calcium diffusion and the time courses of transmitter release and synaptic facilitation at the squid giant synapse

RS Zucker, Norman Stockbridge

Journal of Neuroscience

1983

136

Page 1